HEADER HYDROLASE/HYDROLASE INHIBITOR 13-SEP-90 7HVP TITLE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A SYNTHETIC TITLE 2 PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND A SUBSTRATE-BASED TITLE 3 HYDROXYETHYLAMINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INHIBITOR ACE-SER-LEU-ASN-PHE-PSI(CH(OH)-CH2N)-PRO-ILE VME COMPND 7 (JG-365); COMPND 8 CHAIN: C; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES KEYWDS ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.L.SWAIN,M.M.MILLER,J.GREEN,D.H.RICH,J.SCHNEIDER,S.B.H.KENT, AUTHOR 2 A.WLODAWER REVDAT 7 15-NOV-23 7HVP 1 SEQADV LINK ATOM REVDAT 6 29-NOV-17 7HVP 1 HELIX REVDAT 5 06-AUG-14 7HVP 1 LINK REVDAT 4 13-JUL-11 7HVP 1 VERSN REVDAT 3 24-FEB-09 7HVP 1 VERSN REVDAT 2 01-APR-03 7HVP 1 JRNL REVDAT 1 15-JUL-93 7HVP 0 JRNL AUTH A.L.SWAIN,M.M.MILLER,J.GREEN,D.H.RICH,J.SCHNEIDER,S.B.KENT, JRNL AUTH 2 A.WLODAWER JRNL TITL X-RAY CRYSTALLOGRAPHIC STRUCTURE OF A COMPLEX BETWEEN A JRNL TITL 2 SYNTHETIC PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS 1 AND A JRNL TITL 3 SUBSTRATE-BASED HYDROXYETHYLAMINE INHIBITOR. JRNL REF PROC.NATL.ACAD.SCI.USA V. 87 8805 1990 JRNL REFN ISSN 0027-8424 JRNL PMID 2247451 JRNL DOI 10.1073/PNAS.87.22.8805 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.JASKOLSKI,A.G.TOMASSELLI,T.K.SAWYER,D.G.STAPLES, REMARK 1 AUTH 2 R.L.HEINRIKSON,J.SCHNEIDER,S.B.KENT,A.WLODAWER REMARK 1 TITL STRUCTURE AT 2.5-ANGSTROMS RESOLUTION OF CHEMICALLY REMARK 1 TITL 2 SYNTHESIZED HUMAN IMMUNODEFICIENCY VIRUS TYPE I PROTEASE REMARK 1 TITL 3 COMPLEXED WITH A HYDROXYETHYLENE-BASED INHIBITOR REMARK 1 REF BIOCHEMISTRY V. 30 1600 1991 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.WLODAWER,M.MILLER,M.JASKOLSKI,B.K.SATHYANARAYANA, REMARK 1 AUTH 2 E.BALDWIN,I.T.WEBER,L.M.SELK,L.CLAWSON,J.SCHNEIDER, REMARK 1 AUTH 3 S.B.H.KENT REMARK 1 TITL CONSERVED FOLDING IN RETROVIRAL PROTEASES. CRYSTAL STRUCTURE REMARK 1 TITL 2 OF A SYNTHETIC HIV-1 PROTEASE REMARK 1 REF SCIENCE V. 245 616 1989 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.MILLER,J.SCHNEIDER,B.K.SATHYANARAYANA,M.V.TOTH, REMARK 1 AUTH 2 G.R.MARSHALL,L.CLAWSON,L.SELK,S.B.H.KENT,A.WLODAWER REMARK 1 TITL STRUCTURE OF COMPLEX OF SYNTHETIC HIV-1 PROTEASE WITH A REMARK 1 TITL 2 SUBSTRATE-BASED INHIBITOR AT 2.3 ANGSTROMS RESOLUTION REMARK 1 REF SCIENCE V. 246 1149 1989 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 4 REMARK 1 AUTH I.T.WEBER,M.MILLER,M.JASKOLSKI,J.LEIS,A.M.SKALKA,A.WLODAWER REMARK 1 TITL MOLECULAR MODELING OF THE HIV-1 PROTEASE AND ITS SUBSTRATE REMARK 1 TITL 2 BINDING SITE REMARK 1 REF SCIENCE V. 243 928 1989 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 5 REMARK 1 AUTH M.MILLER,M.JASKOLSKI,J.K.M.RAO,J.LEIS,A.WLODAWER REMARK 1 TITL CRYSTAL STRUCTURE OF A RETROVIRAL PROTEASE PROVES REMARK 1 TITL 2 RELATIONSHIP TO ASPARTIC PROTEASE FAMILY REMARK 1 REF NATURE V. 337 576 1989 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 6 REMARK 1 AUTH J.SCHNEIDER,S.B.H.KENT REMARK 1 TITL ENZYMATIC ACTIVITY OF A SYNTHETIC 99 RESIDUE PROTEIN REMARK 1 TITL 2 CORRESPONDING TO THE PUTATIVE HIV-1 PROTEASE REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 54 363 1988 REMARK 1 REFN ISSN 0092-8674 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROFFT REMARK 3 AUTHORS : KONNERT,HENDRICKSON,FINZEL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 5398 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.146 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1577 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 95 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.020 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.060 ; 0.040 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.050 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.020 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.210 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.220 ; 0.300 REMARK 3 MULTIPLE TORSION (A) : 0.260 ; 0.300 REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : 0.260 ; 0.300 REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 2.400 ; 3.000 REMARK 3 STAGGERED (DEGREES) : 21.900; 10.000 REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.200 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.900 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.500 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.800 ; 4.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7HVP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000179903. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.60000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.40000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.60000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.40000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE PEPTIDE BOND BEFORE THE PRO SUBCOMPONENT IN THE INHIBITOR IS REMARK 400 REPLACED BY A HYDROXYETHYLAMINE GROUP CH(OH)-CH2N. REMARK 400 REMARK 400 THE JG-365 IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: JG-365 REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 315 O HOH B 323 2.06 REMARK 500 O GLN B 58 O HOH B 320 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLN A 2 CB - CA - C ANGL. DEV. = 15.5 DEGREES REMARK 500 GLN A 2 CA - CB - CG ANGL. DEV. = 16.4 DEGREES REMARK 500 THR A 4 CA - CB - OG1 ANGL. DEV. = -13.1 DEGREES REMARK 500 GLN A 7 CA - CB - CG ANGL. DEV. = 32.6 DEGREES REMARK 500 VAL A 11 N - CA - CB ANGL. DEV. = -14.8 DEGREES REMARK 500 ARG A 14 N - CA - CB ANGL. DEV. = 15.5 DEGREES REMARK 500 ILE A 15 CB - CA - C ANGL. DEV. = 12.1 DEGREES REMARK 500 LEU A 19 N - CA - CB ANGL. DEV. = 18.3 DEGREES REMARK 500 LEU A 19 CA - CB - CG ANGL. DEV. = 26.4 DEGREES REMARK 500 LEU A 24 O - C - N ANGL. DEV. = -10.9 DEGREES REMARK 500 LYS A 43 CA - CB - CG ANGL. DEV. = 14.3 DEGREES REMARK 500 ILE A 50 N - CA - CB ANGL. DEV. = 17.6 DEGREES REMARK 500 ILE A 54 N - CA - CB ANGL. DEV. = 15.0 DEGREES REMARK 500 GLN A 61 CB - CG - CD ANGL. DEV. = 19.6 DEGREES REMARK 500 ABA A 67 O - C - N ANGL. DEV. = -10.9 DEGREES REMARK 500 HIS A 69 N - CA - CB ANGL. DEV. = 12.7 DEGREES REMARK 500 VAL A 75 CA - CB - CG2 ANGL. DEV. = 9.7 DEGREES REMARK 500 LEU A 76 CA - CB - CG ANGL. DEV. = 18.4 DEGREES REMARK 500 LEU A 76 CB - CG - CD1 ANGL. DEV. = -10.3 DEGREES REMARK 500 LEU A 89 CA - CB - CG ANGL. DEV. = 18.1 DEGREES REMARK 500 LEU A 97 CA - CB - CG ANGL. DEV. = 18.2 DEGREES REMARK 500 VAL B 11 N - CA - CB ANGL. DEV. = -14.1 DEGREES REMARK 500 VAL B 11 CA - CB - CG1 ANGL. DEV. = 11.0 DEGREES REMARK 500 ARG B 14 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 LEU B 19 CB - CA - C ANGL. DEV. = 13.9 DEGREES REMARK 500 LYS B 20 CB - CG - CD ANGL. DEV. = 24.5 DEGREES REMARK 500 GLU B 21 N - CA - CB ANGL. DEV. = 11.0 DEGREES REMARK 500 GLU B 21 CA - CB - CG ANGL. DEV. = 13.3 DEGREES REMARK 500 ASP B 29 N - CA - CB ANGL. DEV. = 10.9 DEGREES REMARK 500 ASP B 29 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ASP B 30 CB - CG - OD2 ANGL. DEV. = -7.2 DEGREES REMARK 500 ASP B 30 O - C - N ANGL. DEV. = 9.8 DEGREES REMARK 500 VAL B 32 CB - CA - C ANGL. DEV. = 13.0 DEGREES REMARK 500 GLU B 34 OE1 - CD - OE2 ANGL. DEV. = 8.7 DEGREES REMARK 500 LYS B 45 N - CA - CB ANGL. DEV. = 12.3 DEGREES REMARK 500 VAL B 56 O - C - N ANGL. DEV. = 10.7 DEGREES REMARK 500 ARG B 57 CA - CB - CG ANGL. DEV. = 15.1 DEGREES REMARK 500 ARG B 57 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 GLU B 65 CA - CB - CG ANGL. DEV. = 17.5 DEGREES REMARK 500 ILE B 66 CB - CA - C ANGL. DEV. = 15.9 DEGREES REMARK 500 ALA B 71 CB - CA - C ANGL. DEV. = 13.9 DEGREES REMARK 500 ILE B 72 CB - CG1 - CD1 ANGL. DEV. = 18.9 DEGREES REMARK 500 ASN B 83 N - CA - CB ANGL. DEV. = 11.7 DEGREES REMARK 500 ILE B 84 CB - CG1 - CD1 ANGL. DEV. = 18.1 DEGREES REMARK 500 ARG B 87 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 THR B 91 O - C - N ANGL. DEV. = 10.5 DEGREES REMARK 500 THR B 96 OG1 - CB - CG2 ANGL. DEV. = -21.5 DEGREES REMARK 500 LEU B 97 N - CA - CB ANGL. DEV. = 13.7 DEGREES REMARK 500 LEU B 97 CB - CG - CD2 ANGL. DEV. = -11.9 DEGREES REMARK 500 ACE C 0 O - C - N ANGL. DEV. = -15.1 DEGREES REMARK 500 REMARK 500 THIS ENTRY HAS 52 ANGLE DEVIATIONS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 9 60.47 -61.96 REMARK 500 GLN A 61 78.54 15.00 REMARK 500 ASN B 37 68.64 -102.49 REMARK 500 ABA B 67 51.35 35.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 JG3 C 4 ILE C 5 -82.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 JG3 C 4 43.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE DIMER INTERFACE IS COMPOSED OF INTERDIGITATED N- AND REMARK 700 C-TERMINI FROM BOTH SUBUNITS FORMING A FOUR-STRANDED REMARK 700 ANTIPARALLEL BETA-SHEET. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: DTA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: BINDING SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: DTB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: BINDING SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF INHIBITOR ACE-SER REMARK 800 -LEU-ASN-PHE-PSI(CH(OH)-CH2N)-PRO-ILE VME DBREF 7HVP A 1 99 UNP P03369 POL_HV1A2 57 155 DBREF 7HVP B 1 99 UNP P03369 POL_HV1A2 57 155 DBREF 7HVP C 0 6 PDB 7HVP 7HVP 0 6 SEQADV 7HVP ABA A 67 UNP P03369 CYS 123 CONFLICT SEQADV 7HVP ABA A 95 UNP P03369 CYS 151 CONFLICT SEQADV 7HVP ABA B 67 UNP P03369 CYS 123 CONFLICT SEQADV 7HVP ABA B 95 UNP P03369 CYS 151 CONFLICT SEQRES 1 A 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE SEQRES 2 A 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 A 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 6 A 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ABA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE SEQRES 2 B 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 B 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 6 B 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ABA THR LEU ASN PHE SEQRES 1 C 7 ACE SER LEU ASN JG3 ILE VME MODRES 7HVP ABA A 67 ALA ALPHA-AMINOBUTYRIC ACID MODRES 7HVP ABA A 95 ALA ALPHA-AMINOBUTYRIC ACID MODRES 7HVP ABA B 67 ALA ALPHA-AMINOBUTYRIC ACID MODRES 7HVP ABA B 95 ALA ALPHA-AMINOBUTYRIC ACID HET ABA A 67 6 HET ABA A 95 6 HET ABA B 67 6 HET ABA B 95 6 HET ACE C 0 3 HET JG3 C 4 19 HET VME C 6 9 HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM ACE ACETYL GROUP HETNAM JG3 1-[(2S,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-L-PROLINE HETNAM VME METHYL L-VALINATE HETSYN VME O-METHYLVALINE FORMUL 1 ABA 4(C4 H9 N O2) FORMUL 3 ACE C2 H4 O FORMUL 3 JG3 C15 H22 N2 O3 FORMUL 3 VME C6 H13 N O2 FORMUL 4 HOH *95(H2 O) HELIX 1 HA GLY A 86 GLY A 94 1 9 HELIX 2 HB GLY B 86 GLY B 94 1 9 SHEET 1 COA 8 LYS A 43 GLY A 49 0 SHEET 2 COA 8 GLY A 52 ILE A 66 -1 SHEET 3 COA 8 HIS A 69 GLY A 78 -1 SHEET 4 COA 8 THR A 31 GLU A 34 1 SHEET 5 COA 8 ASN A 83 ILE A 85 -1 SHEET 6 COA 8 GLN A 18 ASP A 25 1 SHEET 7 COA 8 PRO A 9 ILE A 15 -1 SHEET 8 COA 8 GLU A 65 ILE A 66 -1 SHEET 1 COB 8 LYS B 43 GLY B 49 0 SHEET 2 COB 8 GLY B 52 ILE B 66 -1 SHEET 3 COB 8 HIS B 69 GLY B 78 -1 SHEET 4 COB 8 THR B 31 GLU B 34 1 SHEET 5 COB 8 ASN B 83 ILE B 85 -1 SHEET 6 COB 8 GLN B 18 ASP B 25 1 SHEET 7 COB 8 PRO B 9 ILE B 15 -1 SHEET 8 COB 8 GLU B 65 ILE B 66 -1 SHEET 1 INT 4 PRO A 1 THR A 4 0 SHEET 2 INT 4 THR B 96 PHE B 99 -1 SHEET 3 INT 4 THR A 96 PHE A 99 -1 SHEET 4 INT 4 PRO B 1 THR B 4 -1 LINK C ILE A 66 N ABA A 67 1555 1555 1.34 LINK C ABA A 67 N GLY A 68 1555 1555 1.34 LINK C GLY A 94 N ABA A 95 1555 1555 1.32 LINK C ABA A 95 N THR A 96 1555 1555 1.32 LINK C ILE B 66 N ABA B 67 1555 1555 1.33 LINK C ABA B 67 N GLY B 68 1555 1555 1.34 LINK C GLY B 94 N ABA B 95 1555 1555 1.32 LINK C ABA B 95 N THR B 96 1555 1555 1.30 LINK C ACE C 0 N SER C 1 1555 1555 1.36 LINK C ASN C 3 N JG3 C 4 1555 1555 1.33 LINK C JG3 C 4 N ILE C 5 1555 1555 1.32 LINK C ILE C 5 N VME C 6 1555 1555 1.32 SITE 1 DTA 3 ASP A 25 THR A 26 GLY A 27 SITE 1 DTB 3 ASP B 25 THR B 26 GLY B 27 SITE 1 AC1 26 ARG A 8 ASP A 25 GLY A 27 ALA A 28 SITE 2 AC1 26 ASP A 29 ASP A 30 ILE A 47 GLY A 48 SITE 3 AC1 26 GLY A 49 ILE A 50 HOH A 318 HOH A 378 SITE 4 AC1 26 ARG B 8 ASP B 25 GLY B 27 ALA B 28 SITE 5 AC1 26 ASP B 29 ASP B 30 ILE B 47 GLY B 48 SITE 6 AC1 26 GLY B 49 ILE B 50 VAL B 82 ILE B 84 SITE 7 AC1 26 HOH C 301 HOH C 395 CRYST1 51.200 58.800 62.000 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019531 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017007 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016129 0.00000